Cargando…
Efficacy and safety of chemotherapy for newly diagnosed advanced non-small cell lung cancer with venous thromboembolism
BACKGROUND: Venous thromboembolism (VTE) is a serious complication in patients with lung cancer. The benefit of chemotherapy for lung cancer patients with VTE remains unknown. This study was conducted to elucidate the efficacy and safety of chemotherapy for advanced non-small cell lung cancer (NSCLC...
Autores principales: | Zhang, Xueli, Li, Huiqiao, Chen, Wenhui, Yang, Yuanhua, Wang, Chen, Zhang, Yuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632931/ https://www.ncbi.nlm.nih.gov/pubmed/26557917 http://dx.doi.org/10.1111/1759-7714.12278 |
Ejemplares similares
-
Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer
por: Zhang, Yuhui, et al.
Publicado: (2016) -
Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer
por: Su, Yanping, et al.
Publicado: (2021) -
Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer
por: Dou, Feifei, et al.
Publicado: (2018) -
Advanced practice provider–led clinic for care transitions in newly diagnosed venous thromboembolism: establishment and utilization
por: Frank, Cassiopeia, et al.
Publicado: (2023) -
Soluble P-selectin level in patients with cancer-associated venous and artery thromboembolism: a systematic review and meta-analysis
por: Zhang, Xueli, et al.
Publicado: (2023)